Neuropsychiatric disorders in Parkinson's disease

被引:8
|
作者
Noé-Sebastián, E [1 ]
Irimia-Sieira, P [1 ]
Pomares-Arias, E [1 ]
Martínez-Vila, E [1 ]
Luquin-Piudo, MR [1 ]
机构
[1] Univ Navarra Clin, Fac Med, Dept Neurol, E-31008 Pamplona, Spain
关键词
neuropsychiatric disorders; Parkinson's disease;
D O I
10.33588/rn.3207.2000179
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective. This paper reviews the main neuropsychiatric disorders associated, with Parkinson's disease (PD) and describes the neuropathological hypothesis proposed to explain these symptoms. Development. This disease is usually associated with neuropsychiatric complications such as depression, anxiety and apathy. Besides, psychiatric symptoms are one of the most common side effects of antiparkinsonian drug-therapy. Conclusions. Depression is the most frequent emotional disorder reported inpatients with PD. Up to 20% of parkinsonian patients meet DSM-IV criteria for major depressive episode and another 20% for dysthymia, while the prevalence of depression in normal aged population is about 2-8%. The relationship between PD and depression has not been fully established Some investigators have suggested that depressive symptoms in PD are causally related to the underlying neuropathological process, affecting predominantly serotoninergic and dopaminergic pathways. Alternatively, depression in PD may represent a normal reaction to the progressive physical impairment induced by the disease. Otherwise, up to 20% of parkinsonian patients present levodopa-induced psychiatric complications. Visual hallucinations are the commonest, but delusions, confusional states, sexual disorders and sleep disorders have also been described Serotonine and dopamine have been implicated in the neuropathological basis of these disorders.
引用
收藏
页码:676 / 681
页数:6
相关论文
共 50 条
  • [21] Drug treatments for the neuropsychiatric complications of Parkinson's disease
    Connolly, Barbara S.
    Fox, Susan H.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2012, 12 (12) : 1439 - 1449
  • [22] Neuropsychiatric Treatments for Parkinson's Disease: Nonpharmacological Approaches
    Mathur, Neha
    Bhatt, Haseel
    Lidstone, Sarah C.
    SEMINARS IN NEUROLOGY, 2022, 42 (02) : 158 - 167
  • [23] Early Signs and Neuropsychiatric Symptoms in Parkinson's Disease
    Kasten, Meike
    Vollstedt, Eva-Juliane
    Klein, Christine
    ZEITSCHRIFT FUR NEUROPSYCHOLOGIE, 2014, 25 (01) : 31 - 38
  • [24] Neuropsychiatric Features of Punding and Hobbyism in Parkinson's Disease
    Barbosa, Pedro
    O'Sullivan, Sean S.
    Joyce, Eileen
    Lees, Andrew J.
    Warner, Thomas T.
    Djamshidian, Atbin
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2022, 9 (01): : 82 - 86
  • [25] Neuropsychiatric Symptoms and Caregiver Burden in Parkinson's Disease
    Juneja, Abhishek
    Anand, Kuljeet
    Chandra, Mina
    Deshpande, Smita
    Dhamija, Rajinder
    Kathuria, Parul
    Mahajan, Rahul
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2020, 23 (05) : 656 - 660
  • [26] An evaluation of neuropsychiatric symptoms in Parkinson's disease patients
    Oruc, S.
    Gulseren, G.
    Kusbeci, O. Y.
    Ozbulut, O.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2017, 20 (07) : 900 - 904
  • [27] Range of neuropsychiatric disturbances in patients with Parkinson's disease
    Aarsland, D
    Larsen, JP
    Lim, NG
    Janvin, C
    Karlsen, K
    Tandberg, E
    Cummings, JL
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 67 (04) : 492 - 496
  • [28] Neuropsychiatric Symptoms in Parkinson's Disease: Beyond Complications
    Kehagia, Angie A.
    FRONTIERS IN PSYCHIATRY, 2016, 7
  • [29] Recognition and treatment of neuropsychiatric disturbances in Parkinson's disease
    Akbar, Umer
    Friedman, Joseph H.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2015, 15 (09) : 1053 - 1065
  • [30] Neuropsychiatric symptoms in Nigerian patients with Parkinson's disease
    Ojagbemi, A. A.
    Akinyemi, R. O.
    Baiyewu, O.
    ACTA NEUROLOGICA SCANDINAVICA, 2013, 128 (01): : 9 - 16